American Century Companies’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
VPM
ACH
VCM
GKIM
DCM
American Century Companies's TNDM Position: Q1 2026 in Review
American Century Companies increased its Tandem Diabetes Care (TNDM) stake by 2.2% in Q1 2026, buying an estimated $15.4K and bringing the position to 33,470 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #2458.
American Century Companies first reported a position in TNDM in Q1 2016 and has held it in 19 quarters since. The position peaked at $75.2M in Q3 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.
- American Century Companies held 33,470 shares of Tandem Diabetes Care worth $642K as of Q1 2026.
- American Century Companies bought 710 Tandem Diabetes Care shares in Q1 2026, an estimated $15.4K.
- Tandem Diabetes Care made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2458 holding.
- American Century Companies first reported a position in Tandem Diabetes Care in Q1 2016 and has held it in 19 quarters since.
- American Century Companies's Tandem Diabetes Care position peaked at $75.2M in Q3 2020.
- 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.